Tears of joy as Pfizer staff told of vaccine breakthrough
polesheep wrote: » Do you think Ireland pre-EU membership could have negotiated the same number of vaccines as speedily?
landofthetree wrote: » Once you have the conkers you can buy it. Eg Switzerland have a deal.https://www.heidi.news/geneva-solutions/switzerland-has-assured-4-5-million-doses-of-future-covid-19-vaccine-through-moderna
10000maniacs wrote: » The scientific data produced by Pfizer will be most important on this new vaccine. 90%+ on a sample of 43,000 people. What were the age ranges of these people? and how many people in that 43,000 had the virus to begin with? If nobody had the virus to begin with and the age range of the participants was 20-80, 90% is worse than the natural recovery rate for this sample in the real world.
CIARAN_BOYLE wrote: » It's 90% on a group of 94 (confirmed cases of covid) among the 43000. Also its not that 90% lived and 10% died. Rather than the people involved in a trial are divided into 2 randomly. Half given the vaccine and half given a placebo. Roughly 85 people in the placebo group have gotten covid compared to roughly 9 in the vaccinated group. They suggest this means that 90% of the people from the vaccinated group did not get covid because of the vaccine.
10000maniacs wrote: » A better solution would be to 50/50 split the vaccine and placebo to people in vulnerable groups. And another 50/50 split to random people with the virus.
big syke wrote: » Why give it to people with the virus???? It is not a treatment its a vaccine. You really arent grasping this well are you?
chrisbonnie wrote: » So you know more than these big pharma companies who, id imagine are experts in their field?
10000maniacs wrote: » Aren't you the smug one? It's you that ain't grasping it. It all depends what type of vaccine it is. And what stage the virus is at in your system. And I meant giving the virus to the subject after the vaccine had been delivered. No need to be so arrogant in your replies.
odyssey06 wrote: » Pot. Kettle. Black. You think it would have been better to skip this phase and go straight to challenge trials? Can you give us a timeline on regulatory approval for skipping this phase of the trial and running challenge trials instead - if apparently you think it a better solution. The number of ppl that would be enrolled in a challenge trial would be a fraction of the current phase.
begbysback wrote: » Is it too late to buy Pfizer shares?
timsey tiger wrote: » One could buy moderna shares, they droped on this news, but if they come up with the goods presently they should rebound. This obviously is not advice and none should be taken from anonomous losers on the internet.
10000maniacs wrote: » All I really said was wait for the scientific report on what Pfizer are actually doing to get these figures. And that's all Dr Sanjay Gupta said too on CNN.
odyssey06 wrote: » At no point did Dr Sanjay Gupta said they should have run challenge trials though. Questions about age range of participants, symptom tracking etc are of course important.
Firstly this is good news. 90% effective! Give people the vaccine and give people placebo and see how effectively it works. But if the question is how effective is it in preventing people from getting sick who are infected, its a good question. 80% of people recover from this virus anyway with no symptoms or minimal symptoms. So it's this vulnerable population, how well will it work for them? How likely will it prevent them from getting sick? How long does it last? These are still unanswered questions. Is the vaccine going to be a yearly thing? If it's two shots, how long after you get the second shot will you have immunity? An entire season? (
MerlinSouthDub wrote: » Booked my flights for next summer when I heard the vaccine news
Sam Hain wrote: » A simpletons chain of reaction.
